No insider purchase over the last 90 days. The latest was filed 09 Jan 2026.
This page follows insider dealings at Prolight Diagnostics AB (publ) as filed with Finansinspektionen, a company from the Health Care sector. In the past year (18 October 2025 to 18 October 2026), 2 filings came from 2 insiders.
The flow runs one way only: 2 insiders bought (2 purchases totalling €39k) and nobody sold on the market. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Biggest ticket of the year: €37k, bought by Ulf Bladin and made public on 9 January 2026. Those buying include 1 board member and 1 chief executive.
For context, the typical company on the same exchange (median of 886 companies) published 7 filings over the same period, against 2 filings here. Over the whole record (from 2025), the tally stands at 2 purchases and no sales.
The latest purchase dates back some time: it was published 282 days ago, on 9 January 2026.
Elsewhere in the same sector, our signals recently picked up insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
· cache
9 of 9 declarations
Prolight Diagnostics AB (publ) is a Swedish company focused on developing medical diagnostic solutions. It is listed on the Stockholm Stock Exchange (XSTO).